Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引：0

作者：

Muddu, V. ^{[1
]}

Shah, A. ^{[2
]}

Raj, A. ^{[3
]}

Bahl, A. ^{[4
]}

Thirumalairaj, R. ^{[5
]}

Ghosh, J. ^{[6
]}

Ostwal, V. ^{[2
]}

Rajappa, S. ^{[7
]}

Vora, A. ^{[8
]}

Lavingia, V. ^{[9
]}

Sharma, A. ^{[10
]}

Khan, A. ^{[1
]}

Rohatgi, N. ^{[4
]}

Mahajan, M. ^{[11
]}

Chandrakanth, M. ^{[6
]}

Ramaswamy, A. ^{[12
]}

机构：

[1] AIG Hosp, Hyderabad, India

[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India

[3] Sarvodaya Hosp, Faridabad, India

[4] Fortis Canc Inst, Gurgaon, India

[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India

[6] Tata Med Ctr, Kolkata, India

[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India

[8] HOPE Oncol Care Clin, New Delhi, India

[9] HCG Canc Ctr, Ahmadabad, Gujarat, India

[10] All India Inst Med Sci, New Delhi, India

[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India

[12] Tata Mem Hosp, Mumbai, Maharashtra, India

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.04.265

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-209

引用

页码：S90 / S90

页数：1

共 50 条

[31] Biliary tract cancers (BTC): Descriptive and prognostic analyses from a large real-world dataset: The BITCOIN 2 study
Rizzato, M. D.
Angerilli, V.
De Rosa, A.
Sacchi, D.
Barsotti, G.
Piva, V. M.
De Grandis, M. C.
Solda, C.
Intini, R.
Prete, A. A.
Sabbadin, M.
Cerantola, R.
Cerma, K.
Procaccio, L.
Ceccon, C.
Perissinotto, E.
Carcea, E.
Lonardi, S.
Bergamo, F.
Fassan, M.
ANNALS OF ONCOLOGY, 2024, 35 : S128 - S128
[32] TREATMENT WITH GEMCITABINE/CISPLATIN AND DURVALUMAB FOR BILIARY TRACT CANCER - FIRST REAL-WORLD DATA FROM A GERMAN PATIENT COHORT
Gerhardt, Florian
Mueller, Christian
Chater, Jack
Schindler, Aaron
Ebel, Sebastian
Venerito, Marino
Berg, Thomas
Van Boemmel, Florian
HEPATOLOGY, 2023, 78 : S1905 - S1905
[33] Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
Wang, Yaoqun
Wen, Ningyuan
Wang, Shaofeng
Nie, Guilin
Tian, Yuan
Lu, Jiong
Li, Bei
BMC CANCER, 2023, 23 (01)
[34] Treatment of advanced biliary tract cancers: from chemotherapy to targeted agents
Casolino, Raffaella
Braconi, Chiara
HEPATOMA RESEARCH, 2021, 7
[35] Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review
Yaoqun Wang
Ningyuan Wen
Shaofeng Wang
Guilin Nie
Yuan Tian
Jiong Lu
Bei Li
BMC Cancer, 23
[36] A real-world study of the efficacy and safety of anti-programmed cell death-1 therapy combined with chemotherapy or targeted therapy in patients with advanced biliary tract cancer
Sun, Danyang
Ma, Junxun
Wang, Jinliang
Wang, Lijie
Zhang, Sujie
Chen, Guangying
Li, Xiaoyan
Cui, Pengfei
Zheng, Xuan
Hu, Yi
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (06) : 1421 - +
[37] Impact of adjuvant chemotherapy for patients with locally advanced upper tract urothelial carcinoma in real-world clinical practice
Teishima, Jun
Hirata, Junichiro
Toge, Takuya
Uematsu, Riku
Mita, Yoshie
Yoshii, Takahiko
Nakamura, Ichiro
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2024, 18 (01): : E32 - E36
[38] Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers
Mathers, Brittney
Abadi, Shirin
Davies, Janine M.
McIntyre, Connor
Ho, Cheryl
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, : 1381 - 1386
[39] Real-World Study of Treatment with Pembrolizumab Among Patients with Advanced Urothelial Tract Cancer in Denmark
Omland, Lise Hoj
Stormoen, Dag Rune
Dohn, Line Hammer
Carus, Andreas
Als, Anne Birgitte
Jensen, Niels Viggo
Taarnhoj, Gry Assam
Tolver, Anders
Pappot, Helle
BLADDER CANCER, 2021, 7 (04) : 413 - 425
[40] Correction to: Durvalumab: A Review in Advanced Biliary Tract Cancer
Simon Fung
Yahiya Y. Syed
Targeted Oncology, 2024, 19 (1) : 129 - 129

← 1 2 3 4 5 →